{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:46:14Z","timestamp":1792431974095,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473259"],"award-info":[{"award-number":["81473259"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejphar.2017.11.033","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T10:17:34Z","timestamp":1511345854000},"page":"604-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke"],"prefix":"10.1016","volume":"818","author":[{"given":"Yang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Han","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Guang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Guo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.11.033_bib1","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1161\/CIRCULATIONAHA.107.181486","volume":"115","author":"Adams","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2017.11.033_bib2","doi-asserted-by":"crossref","first-page":"14918","DOI":"10.3390\/molecules171214918","article-title":"Hydroxysafflor yellow A (HSYA) from flowers of Carthamus tinctorius L. and its vasodilatation effects on pulmonary artery","volume":"17","author":"Bai","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2017.11.033_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.STR.0000109769.22917.B0","article-title":"Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injuryand poor stroke outcome","volume":"35","author":"Castillo","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2017.11.033_bib4","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1007\/s11064-013-1135-8","article-title":"Hydroxysafflor yellow A protects against cerebral ischemia-reperfusion injury by anti-apoptotic effect through PI3K\/Akt\/GSK3beta pathway in rat","volume":"38","author":"Chen","year":"2013","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2017.11.033_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pathophys.2009.12.001","article-title":"Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis","volume":"17","author":"Deb","year":"2010","journal-title":"Pathophysiology"},{"key":"10.1016\/j.ejphar.2017.11.033_bib6","doi-asserted-by":"crossref","first-page":"40584","DOI":"10.1038\/srep40584","article-title":"Hydroxysafflor yellow A attenuates the expression of inflammatory cytokines in acute soft tissue injury","volume":"7","author":"Dong","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2017.11.033_bib7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/cns.12057","article-title":"Effects of combination therapy with levamlodipine and bisoprolol on stroke in rats","volume":"19","author":"Gui","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2017.11.033_bib8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/jcbfm.2014.240","article-title":"TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia\/reperfusion injury in mice","volume":"35","author":"Hua","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ejphar.2017.11.033_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vph.2008.11.009","article-title":"Effect of hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia","volume":"50","author":"Ji","year":"2009","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.11.033_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.intimp.2014.10.018","article-title":"Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways","volume":"23","author":"Liu","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejphar.2017.11.033_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1440-1681.2007.04814.x","article-title":"Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening","volume":"35","author":"Liu","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2017.11.033_bib12","first-page":"2709","article-title":"Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobicnanoparticles","volume":"8","author":"Lv","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejphar.2017.11.033_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejphar.2015.11.036","article-title":"Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway","volume":"769","author":"Lv","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.11.033_bib14","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.3390\/ijms130911753","article-title":"Neuroprotection for stroke: current status and future perspectives","volume":"13","author":"Minnerup","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2017.11.033_bib15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jep.2011.11.054","article-title":"The effects of hydroxysafflor yellow A on blood pressure and cardiac function","volume":"139","author":"Nie","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2017.11.033_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.20741","article-title":"1,026 experimental treatments in acute stroke","volume":"59","author":"O'Collins","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2017.11.033_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.HYP.23.1.131","article-title":"Pathophysiology and management of hypertension in acute ischemic stroke","volume":"23","author":"Phillips","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2017.11.033_bib18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12975-014-0346-x","article-title":"AKT-related autophagy contributes to the neuroprotective efficacy of hydroxysafflor yellow A against ischemic stroke in rats","volume":"5","author":"Qi","year":"2014","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.ejphar.2017.11.033_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/jbcpp-2015-0021","article-title":"Neuroprotective effect of hydroxy safflor yellow A against cerebral ischemia-reperfusion injury in rats: putative role of mPTP","volume":"27","author":"Ramagiri","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.11.033_bib20","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/cns.12558","article-title":"Sodium Sulfide, a Hydrogen Sulfide-Releasing Molecule, Attenuates Acute Cerebral Ischemia in Rats","volume":"22","author":"Shi","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2017.11.033_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1755-5949.2012.00302.x","article-title":"Risperidone enhances the vulnerability to stroke in hypertensive rats","volume":"18","author":"Song","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2017.11.033_bib22","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/ptr.3166","article-title":"The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonaryinflammatory injury in mice","volume":"24","author":"Sun","year":"2010","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejphar.2017.11.033_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brainres.2012.07.047","article-title":"Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: inhibition of protein oxidation\/nitration, 12\/15-lipoxygenase and blood-brain barrier disruption","volume":"1473","author":"Sun","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2017.11.033_bib24","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1016\/j.bmcl.2010.05.076","article-title":"Hydroxysafflor yellow A suppresses thrombin generation and inflammatory responses following focal cerebral ischemia-reperfusion in rats","volume":"20","author":"Sun","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2017.11.033_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/cns.12142","article-title":"MicroRNA-124 protects neurons against apoptosis in cerebral ischemic stroke","volume":"19","author":"Sun","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2017.11.033_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000141653","article-title":"Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action","volume":"82","author":"Tian","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2017.11.033_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.phymed.2013.09.018","article-title":"Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation","volume":"21","author":"Wang","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2017.11.033_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2005.05.069","article-title":"Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action","volume":"386","author":"Wei","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2017.11.033_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1248\/bpb.35.515","article-title":"Hydroxysafflor yellow A alleviates early inflammatory response of bleomycin-induced mice lung injury","volume":"35","author":"Wu","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2017.11.033_bib30","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s12272-001-1261-y","article-title":"Hydroxysafflor yellow A protects neuron against hypoxia injury and suppresses inflammatory responses following focal ischemia reperfusion in rats","volume":"31","author":"Ye","year":"2008","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejphar.2017.11.033_bib31","doi-asserted-by":"crossref","first-page":"e110124","DOI":"10.1371\/journal.pone.0110124","article-title":"Effects of danshensu on platelet aggregation and thrombosis: in vivo arteriovenous shunt and venous thrombosis models in rats","volume":"9","author":"Yu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2017.11.033_bib32","first-page":"696","article-title":"[Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor]","volume":"37","author":"Zang","year":"2002","journal-title":"Yao Xue Xue Bao"},{"key":"10.1016\/j.ejphar.2017.11.033_bib33","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1113\/jphysiol.2011.213686","article-title":"Paradoxical effects of streptozotocin-induced diabetes on endothelial dysfunction in stroke-prone spontaneously hypertensive rats","volume":"589","author":"Zhong","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2017.11.033_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-2003-39714","article-title":"Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies","volume":"69","author":"Zhu","year":"2003","journal-title":"Planta Med."},{"key":"10.1016\/j.ejphar.2017.11.033_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/10286020310001625120","article-title":"Therapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms","volume":"7","author":"Zhu","year":"2005","journal-title":"J. Asian Nat. Prod. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917307665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917307665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:29:02Z","timestamp":1757975342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917307665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":35,"alternative-id":["S0014299917307665"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.033","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}